May 11, 2018 8:30 am EDT EyeGate Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
Apr 9, 2018 8:30 am EDT EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Apr 6, 2018 8:30 am EDT EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
Mar 8, 2018 8:30 am EST EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Mar 2, 2018 4:28 pm EST EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update